Literature DB >> 35316521

Prognostic analysis and clinical characteristics of dual primary lung cancer: a population study based on surveillance, epidemiology, and end results (SEER) database.

Guanghui Wang1,2, Yukai Zeng1, Haotian Zheng1, Xiaogang Zhao3, Yadong Wang1, Hongchang Shen1, Jiajun Du4,5.   

Abstract

BACKGROUND: The peculiarity and the lack of clinical studies of dual primary lung cancer (DPLC) led to limited knowledge about its clinical characteristics and prognosis. This study performed a retrospective analysis to assess the prognostic factors and clinical characteristics of DPLC.
METHODS: A total of 1419 DPLC patients from SEER were analyzed by univariate and multivariable Cox regression analyses. The independent prognostic factors were included to establish a nomogram. The accuracy and reliability of prognostic model were evaluated by C indexes, calibration plots, receiver operating characteristic (ROC) curves, decision curve analyses (DCA) and integrated discrimination improvement (IDI) scores. Chi-square test was used to assess the differences between DPLC and single primary lung cancer (SPLC) or synchronous DPLC (sDPLC) and metachronous DPLC (mDPLC).
RESULTS: Cox regression analysis showed that age, sex, histological type, stage, lymph node (LN) metastasis, surgery, chemotherapy were independent prognostic factors, we included these factors to establish a nomogram. In the training cohort, the C index was 0.690, and the area under curves (AUC) of 3 and 5-year survival time were 0.720 and 0.723. The calibration plots in training cohort and validation cohort were in excellent agreement. DCA and IDI showed that the predictive effect of the novel prognostic model was better than the model based on 8th AJCC TNM system. Chi-square test indicated that DPLC and SPLC had statistical differences on pathological and clinical features.
CONCLUSIONS: The clinical and pathological characteristics of DPLC were different from the SPLC. The nomogram could provide accurate and individualized survival predictions for DPLC.
© 2022. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.

Entities:  

Keywords:  COX analysis; Dual primary lung cancer; End Results database; Epidemiology; Nomogram; Prognostic model; The Surveillance

Mesh:

Year:  2022        PMID: 35316521     DOI: 10.1007/s11748-022-01795-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  13 in total

Review 1.  How to build and interpret a nomogram for cancer prognosis.

Authors:  Alexia Iasonos; Deborah Schrag; Ganesh V Raj; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

2.  Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy.

Authors:  Kimberly M Creach; Issam El Naqa; Jeffrey D Bradley; Jeffrey R Olsen; Parag J Parikh; Robert E Drzymala; Charles Bloch; Clifford G Robinson
Journal:  Radiother Oncol       Date:  2012-03-03       Impact factor: 6.280

3.  Surgery for metachronous second primary lung cancer versus surgery for primary lung cancer: a propensity score-matched comparison of postoperative complications and survival outcomes.

Authors:  Yusuke Muranishi; Makoto Sonobe; Masatsugu Hamaji; Atsushi Kawaguchi; Kyoko Hijiya; Hideki Motoyama; Toshi Menju; Akihiro Aoyama; Toyofumi F Chen-Yoshikawa; Toshihiko Sato; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2018-04-01

Review 4.  Soft tissue sarcoma nomograms and their incorporation into practice.

Authors:  Dario Callegaro; Rosalba Miceli; Luigi Mariani; Chandrajit P Raut; Alessandro Gronchi
Journal:  Cancer       Date:  2017-05-10       Impact factor: 6.860

5.  Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.

Authors:  Masatsugu Hamaji; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Francis C Nichols; Dennis A Wigle; K Robert Shen
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03       Impact factor: 5.209

Review 6.  Nomograms are key decision-making tools in prostate cancer radiation therapy.

Authors:  Sarah Caulfield; Gerard Menezes; Laure Marignol; Claire Poole
Journal:  Urol Oncol       Date:  2018-04-19       Impact factor: 3.498

7.  A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients.

Authors:  Ikuo Sekine; Yasushi Shintani; Takehito Shukuya; Koichi Takayama; Akira Inoue; Isamu Okamoto; Katsuyuki Kiura; Kazuhisa Takahashi; Hirotoshi Dosaka-Akita; Yuichi Takiguchi; Etsuo Miyaoka; Meinoshin Okumura; Ichiro Yoshino
Journal:  Cancer Sci       Date:  2020-03-25       Impact factor: 6.716

8.  Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients.

Authors:  Zhicheng Hu; Yanchao Rong; Shuting Li; Shanqiang Qu; Shaobin Huang
Journal:  Cancer Manag Res       Date:  2020-12-17       Impact factor: 3.989

9.  Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis.

Authors:  QiHao Tu; Chuan Hu; Hao Zhang; Chen Peng; Meng Kong; MengXiong Song; Chong Zhao; YuJue Wang; Jianyi Li; ChuanLi Zhou; Chao Wang; XueXiao Ma
Journal:  Biomed Res Int       Date:  2020-12-08       Impact factor: 3.411

10.  Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.

Authors:  Yun Chen; Hanyu Qiu; Xiaomei Zhang
Journal:  BMC Surg       Date:  2019-12-12       Impact factor: 2.102

View more
  1 in total

1.  Editorial on "robotic versus thoracoscopic combined anatomic subsegmentectomy for early stage lung cancer: early results of a cohort study".

Authors:  Takuro Miyazaki; Takeshi Nagayasu
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.